U.S. Esoteric Testing Market worth USD 9.5 billion by 2030

Date: Apr 2022

The Market Statsville Group (MSG) publishes the new report on the "U.S. Esoteric Testing Market by Type (Endocrinology, Genetics, Immunology, Infectious Disease, and Oncology), by Technology Outlook (Immunoassay, LC-MS/MS, RT-PCR, Flow Cytometry, and Gene Sequencing), by Patient Type (Inpatient Testing and Outpatient Testing) – U.S. Share and Forecast to 2030".

The U.S. esoteric testing market size is expected to grow from USD 5.7 billion in 2021 to USD 9.5 billion by 2030, registering a CAGR of 6.7% during the forecast period. Precision medicines and personalized medicines are witnessing an increased usage in the healthcare sector. Precision medicine is the practice of administering the right medicine to the right patient at the right time. Personalized medicines, on the other hand, is providing medicine that is tailored specifically for a certain patient. The idea of precision medicine was facilitated by pharmaceutical companies performing research and development at the molecular and genetic levels to understand the susceptibility of a person to various diseases.

Precision medicines and personalized medicines are witnessing increased usage in the healthcare sector. Precision medicine is administering the right medicine to the right patient at the right time. On the other hand, personalized medicines provide medicine that is tailored specifically for a certain patient. The idea of precision medicine was facilitated by pharmaceutical companies performing research and development at the molecular and genetic levels to understand a person's susceptibility to various diseases.

U.S. Esoteric Testing Market Segmentation

The U.S. esoteric testing market has been segmented into type, technology, and patient type.

  • By Type (Endocrinology, Genetics, Immunology, Infectious Disease, Oncology, and Others)
  • By Technology (Immunoassay, LC-MS/MS, RT-PCR, Flow Cytometry, Gene Sequencing, and Others)
  • By Patient Type (Inpatient Testing and Outpatient Testing)

LC-MS/MS, by technology, is estimated to hold the largest market share during the forecast period

Based on technology, the U.S. esoteric testing market is segregated into Immunoassay, LC-MS/MS, RT-PCR, Flow Cytometry, Gene Sequencing, and Others. The LC-MS/MS segment generated the highest revenue of 23.5% in the U.S. esoteric testing market in 2021, and it is expected to register a significant CAGR from 2022 to 2030. Liquid chromatography and mass spectrometry are two commonly used analytical techniques in laboratory science due to their accuracy and efficiency. MS or mass spectrometry detects the mass to charge ratio of one or more molecules present in the sample. MS is used to measure the molecular weight of unknown compounds. It is also used to detect the molecular weight of known molecules and their structure and chemical properties.

Liquid chromatography-tandem mass spectrometry, i.e., LC-MS/MS, is a modified liquid chromatography and mass spectrometry application. It combines the separating power of liquid chromatography with the high sensitivity and selective mass analysis capability of mass spectrometry. In LC-MS/MS system, the process starts with liquid chromatography. In liquid chromatography, the sample is mixed with the mobile phase and then allowed to flow through the stationary phase at high pressure.

Don't miss out on business opportunities in U.S. Esoteric Testing Market. Speak to our research analyst and gain crucial market insights that will benefit your business grow.

This research report examines the development and marketing strategies and the product portfolios and winning strategies of the leading companies in the esoteric testing market in the United States. It also consists of the profiles of leading companies such as Laboratory Corporation of America, Mayo Medical Laboratories, Opko Health Company, Invitae, Myriad Genetics, Miraca Holdings Inc., Genomic Health, and Fulgent Genetics Inc. These market players have focused on acquisitions and expansion to gain a larger market share in the U.S. esoteric testing market.

Browse complete report: https://www.marketstatsville.com/united-states-esoteric-testing-market

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

416, East Standsberry Street, Perkins, Oklahoma 74059, USA

USA: +1-580-205-2707 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. I Accept